ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
125.534,07
0,00%
S&P 500
6.061,48
0,39%
US Dollar vs BRL
5,81
0,10%
Bitcoin
98.256,25
1,69%
Brent Oil
74,815
0,32%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Achieve Life Sciences Inc (ACHV)

  7. Achieve Life Sciences Inc (ACHV) Notícias

ACHV

Achieve Life Sciences (ACHV)

Achieve Life Sciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ACHV
DataHoraFonteTítuloCódigoCompanhia
30/01/202518:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
14/01/202518:38Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
10/01/202518:05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ACHVAchieve Life Sciences Inc
10/01/202511:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACHVAchieve Life Sciences Inc
10/01/202510:30GlobeNewswire Inc.Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of DirectorsNASDAQ:ACHVAchieve Life Sciences Inc
07/01/202510:30GlobeNewswire Inc.Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA SubmissionNASDAQ:ACHVAchieve Life Sciences Inc
06/01/202510:30GlobeNewswire Inc.Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference WeekNASDAQ:ACHVAchieve Life Sciences Inc
09/12/202410:30GlobeNewswire Inc.Achieve Life Sciences Appoints Mark Oki as Chief Financial OfficerNASDAQ:ACHVAchieve Life Sciences Inc
03/12/202410:30GlobeNewswire Inc.Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDANASDAQ:ACHVAchieve Life Sciences Inc
19/11/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACHVAchieve Life Sciences Inc
14/11/202410:30GlobeNewswire Inc.Achieve Life Sciences Announces Participation at Upcoming Investor ConferencesNASDAQ:ACHVAchieve Life Sciences Inc
07/11/202418:39Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ACHVAchieve Life Sciences Inc
07/11/202418:25Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ACHVAchieve Life Sciences Inc
07/11/202418:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACHVAchieve Life Sciences Inc
07/11/202418:05GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
25/10/202417:53Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ACHVAchieve Life Sciences Inc
24/10/202409:00GlobeNewswire Inc.Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024NASDAQ:ACHVAchieve Life Sciences Inc
23/10/202409:00GlobeNewswire Inc.Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public MeetingNASDAQ:ACHVAchieve Life Sciences Inc
16/10/202409:00GlobeNewswire Inc.Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of CytisiniclineNASDAQ:ACHVAchieve Life Sciences Inc
10/10/202409:00GlobeNewswire Inc.Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee MeetingNASDAQ:ACHVAchieve Life Sciences Inc
01/10/202409:45GlobeNewswire Inc.Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical AffairsNASDAQ:ACHVAchieve Life Sciences Inc
27/09/202417:46Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACHVAchieve Life Sciences Inc
26/08/202417:30GlobeNewswire Inc.Achieve Life Sciences Announces Changes in Executive Leadership and Board of DirectorsNASDAQ:ACHVAchieve Life Sciences Inc
13/08/202417:01GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
31/07/202409:00GlobeNewswire Inc.Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine DependenceNASDAQ:ACHVAchieve Life Sciences Inc
29/07/202409:00GlobeNewswire Inc.Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley BankNASDAQ:ACHVAchieve Life Sciences Inc
25/07/202409:00GlobeNewswire Inc.Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024NASDAQ:ACHVAchieve Life Sciences Inc
09/07/202409:00GlobeNewswire Inc.Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024NASDAQ:ACHVAchieve Life Sciences Inc
01/07/202409:00GlobeNewswire Inc.Achieve Life Sciences Announces Addition to the U.S. Russell 3000® and Russell Microcap® IndexesNASDAQ:ACHVAchieve Life Sciences Inc
29/05/202409:00GlobeNewswire Inc.Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-CigarettesNASDAQ:ACHVAchieve Life Sciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ACHV

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
INBR32
Inter &
BOV
GFSA3
GAFISA ON
BOV
FICT3
Fictor Alimentos ON
BOV
AGXY3
Agrogalaxy Participacoes ON
BOV
AMAR3
LOJAS MARISA ON
BOV
BRAV3
Brava Energia ON
BOV
TEKA4
TEKA PN
BOV
RNEW4
RENOVA PN
BOV
RAIZ4
Raizen S.A PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios